Deka Bank Deutsche Girozentrale Dbv Technologies S.A. Transaction History

Deka Bank Deutsche Girozentrale

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$6.75 - $11.15 $137,700 - $227,460	-20,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.57 - $10.72 $174,828 - $218,688	-20,400 Reduced 50.0%	20,400 $175,000
Q2 2019 Aug 01, 2019	BUY	$7.58 - $10.0 $291,072 - $384,000	38,400 Added 1600.0%	40,800 $325,000
Q1 2019 May 10, 2019	SELL	$5.81 - $9.37 $104,580 - $168,660	-18,000 Reduced 88.24%	2,400 $53,000
Q4 2018 Feb 12, 2019	BUY	$5.75 - $21.85 $103,500 - $393,300	18,000 Added 750.0%	20,400 $125,000
Q2 2018 Aug 14, 2018	SELL	$18.6 - $24.94 $202,740 - $271,846	-10,900 Reduced 81.95%	2,400 $45,000
Q1 2018 May 03, 2018	SELL	$20.86 - $26.6 $4,172 - $5,320	-200 Reduced 1.48%	13,300 $311,000
Q3 2017 Nov 06, 2017	BUY	$39.62 - $46.17 $534,870 - $623,295	13,500	13,500 $586,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.